Transcription of Historical Comparisons of Morbidity and Mortality for ...
{{id}} {{{paragraph}}}
Example: stock market
Historical Comparisons of Morbidity and Mortality for ...
ORIGINAL CONTRIBUTIONH istorical Comparisons of Morbidityand Mortality for Vaccine-PreventableDiseases in the United StatesSandra W. Roush, MT, MPHT rudy V. Murphy, MDand the Vaccine-Preventable DiseaseTable Working GroupVACCINES ARE AMONG THEgreatest achievements of bio-medical science and publichealth,1,2stimulatingprotectiveimm une responses against acute andchronic infectious diseases, as well assome infectious diseases that result the United States, vaccina-tion programs have made a major con-tribution to the elimination of manyvaccine-preventablediseasesandsignif i-cantly reduced the incidence of thecostsincludemissedtimefromschoolandwo rk,phy-sicianofficevisits, for use of vaccines to prevent oreliminate17vaccine-preventablediseases ,namelydiphtheria,pertussis,tetanus,po-l iomyelitis,measles,mumps, rubella (in-clud ingcongenitalrubellasyndrome),in-fluenza ,invasiveHaemophilusinfluenzaetypeb(Hib) ,hepatitisB,hepatitisA,ro-tavirus,varice lla,herpeszoster(shingles)
Rubella and Congenital Rubella Syndrome (CRS) bFor rubella, number of reported cases for 1966-196863; for CRS, num-ber is averaged from retrospective surveys (1966-1969).64 cFor rubella, reported number of deaths, 1966-196854 dPeak reported number of rubella cases, associated with the 1964-1965epidemic65;forCRS,numberisestimated,associatedwiththe
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: